Cargando…
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
Since the clear demonstration of lysophosphatidic acid (LPA)’s pathological roles in cancer in the mid-1990s, more than 1000 papers relating LPA to various types of cancer were published. Through these studies, LPA was established as a target for cancer. Although LPA-related inhibitors entered clini...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826372/ https://www.ncbi.nlm.nih.gov/pubmed/31658655 http://dx.doi.org/10.3390/cancers11101523 |